Literature DB >> 1142513

Elective transcatheter renal artery occlusion prior to nephrectomy.

Y Ben-Menachem, C M Crigler, J N Corriere.   

Abstract

An hour before nephrectomy 10 patients with hypernephroma and 2 with pyonephrosis underwent occlusion of the renal arteries with gelfoam via selective catheterization, using the Seldinger percutaneous technique. This technique facilitated the operation by collapsing the renal and perirenal veins, decreased blood loss and prevented the dissemination of tumor cells or septic emboli from organ manipulation.

Entities:  

Mesh:

Year:  1975        PMID: 1142513     DOI: 10.1016/s0022-5347(17)67028-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Transcatheter therapeutic embolization of genitourinary pathology.

Authors:  J F Ward; T E Velling
Journal:  Rev Urol       Date:  2000

2.  Occlusion arteriography: diagnostic and therapeutic applicability of balloon catheters.

Authors:  J Weber; D Novak
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

3.  Renal arterial embolization in cases of renal neoplasms. Own experiences.

Authors:  S Wesolowski; S Malanowska; M Czaplicki; A Borkowski; A W Malewski
Journal:  Int Urol Nephrol       Date:  1980       Impact factor: 2.370

4.  Transcatheter obliteration of the renal artery by ethanol injection: experimental results.

Authors:  L Ekelund; N Jonsson; H Treugut
Journal:  Cardiovasc Intervent Radiol       Date:  1981       Impact factor: 2.740

5.  Preoperative arterial occlusion in renal tumors: 3 years experience.

Authors:  G Mobilio; A Cavalli; G Bianchi
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

6.  Spinal cord damage as a complication of renal artery embolization in patients with renal carcinoma.

Authors:  J B Milewski; A W Malewski; S Malanowska; A Borkowski; I A Skowrónski; Z Tomankiewicz; E Sawicka
Journal:  Int Urol Nephrol       Date:  1981       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.